FIRST SESSION: State of the artChairs: Volker Schuster and Carlo Giaquinto

9:00 Welcome and OpeningMichael Borte, Hans-Iko Huppertz, Volker Schuster

9.10 Rotavirus infection and vaccination: basic facts Hans-Iko Huppertz

9.30 Progress in expansion of rotavirus vaccination in Europe since the 2nd expert meeting in 2011Timo Vesikari

9.50 Update on effectiveness and use of pentavalent rotavirus vaccine, RotaTeqtba

10.10 Update on effectiveness and use of human rotavirus vaccine, Rotarixtba

10.30 Coffee Break

SECOND SESSION: Special TopicsChairs: Michael Borte and Timo Vesikari

11.00 Expansion of rotavirus vaccination in GAVI-eligible countries Duncan Steele

11.20 Porcine circovirus update Federico Martinón-Torres

11.40 Intussusception surveillance in the Americas Manish Patel

12.10 Intussusception reporting in Europe Doris Oberle

12.30 Lunch

THIRD SESSION: Experience with RV universal mass vaccination (UMV)Chairs: Hans-Iko Huppertz and Philippe Lepage

13.30 Unexpected benefits of RV vaccination in the USRoger Glass

FIFTH SESSION: Current Research (1)Chair: Hans-Iko Huppertz

09.00 Molecular epidemiology of rotavirus after UMV in Belgium Jelle Matthijnssens

09.20 RotaTeq double reassortants in vaccine recipients Maria Hemming

09.35 Rotaviruses in Brazil Marco Sáfadi (tbc)

09.50 Resurrection of RotaShield George Armah

10.10 RV in infants with immunodeficiency (including HIV) Carlo Giaquinto

10.30 Coffee Break

SIXTH SESSION: Current Research (2)Chairs: Michael Borte and Pierre van Damme

11.00 RV vaccines in neonates and prematures Pierre van Damme

11.20 Prevention of nosocomial RV infection Patricia Bruijning-Verhagen

11.40 Lactobacillus-mediated protection against rotavirus infectionLennart Hammarström

12.00 Health economics and cost effectiveness tba

12.30 Closing remarks Michael Borte, Hans-Iko Huppertz, Volker Schuster

12.40 Lunch and Departures

13.50 Success of rotavirus UMV in Europe: Austria tbaBelgium Philippe LepageFinland Timo VesikariIsrael Ron Dagan

14.10 Impact of rotavirus vaccination on reducing hospitalizations and deaths from diarrhea in Latin AmericaUmesh Parashar

14.20 Experience of RV vaccination in German Federal States Michael Borte, Volker Schuster, Dietmar Beier, Holm Uhlig, Petra Kaiser

15.30 Coffee Break

FOURTH SESSION: Way forward in EuropeChairs: Volker Schuster

16.00 Status of introduction of RV UMV in Greece Vana Sponlou Latvia Dace ZavadskaNorway Synne Sandbu

16.30 RV Vaccination in Eastern EuropePoland tba Hungary Sophia Meszner Overall picture and comparison in Central and Eastern European countries Roman Prymula Rotavirus Surveillance Network (Georgia, Tajikistan and Ukraine) Duncan Steele

17.15 Panel Discussion: Overcoming hurdles for rotavirus UMV in European countries Carlo Giaquinto (Chair), Adam Finn, Hans-Iko Huppertz, Philippe Lepage

20.00 Social Evening at the Leipzig Zoo

Tuesday, 23 April 2013

Wednesday, 24 April 2013

Local OrganizersProf. Dr. Michael BortePhone: +49-341-9093604E-Mail: Michael.Borte@ sanktgeorg.de Prof. Dr. Hans-Iko HuppertzPhone: +49-421-497-5411 E-Mail: hans-iko.huppertz@ med.uni-goettingen.de

Prof. Dr. Volker Schuster Phone: +49-341-9726844E-Mail: volker.schuster@ medizin.uni-leipzig.de

VenueLeipziger KUBUS

– Das Konferenz- und Bildungszentrum des UFZ Permoserstraße 1504318 Leipzig/Germany

www.rotavirus-leipzig.de

Conference Officeevent lab. GmbHDufourstraße 1504107 Leipzig/GermanyProject Management: Nancy KleinE-Mail: nklein@eventlab.orgPhone: +49-341-240596-60www.eventlab.org

Conference FeesRegular Participants: 80,00 EUR (incl. 19% VAT)

Students: 40,00 EUR (incl. 19% VAT)

!